au kan udelukkes, bør samtidig administrering af kendte CYP3A4 inhibitorer (f. eks. erythromycin, itaconazol, ketoconazol og diltiazem) til patienter med udbredte og/ eller erythrodermiske lidelser ske med forsigtighed. e Man har ikke undersøgt den mulige interaktion mellem vaccination og brug af Protopy salve.
er possibility of interactions cannot be ruled out and the concomitant systemic administration of known CYP3A4 inhibitors (e. g. erythromycin, itraconazole, ketoconazole and diltiazem) in patients with ng widespread and/ or erythrodermic disease should be done with caution. lo A potential interaction between vaccination and application of Protopy ointment has not been investigated.